Correlation Engine 2.0
Clear Search sequence regions


  • antivirals (6)
  • cellular (1)
  • cyclosporin (5)
  • CypA (2)
  • direct (6)
  • hepacivirus (1)
  • humans (1)
  • interferon (1)
  • NS3 (2)
  • viral proteins (1)
  • Sizes of these terms reflect their relevance to your search.

    Several direct-acting antivirals (DAAs) are available, providing interferon-free strategies for a hepatitis C cure. In contrast to DAAs, host-targeting agents (HTAs) interfere with host cellular factors that are essential in the viral replication cycle; as host genes, they are less likely to rapidly mutate under drug pressure, thus potentially exhibiting a high barrier to resistance, in addition to distinct mechanisms of action. We compared the effects of cyclosporin A (CsA), a HTA that targets cyclophilin A (CypA), to DAAs, including inhibitors of nonstructural protein 5A (NS5A), NS3/4A, and NS5B, in Huh7.5.1 cells. Our data show that CsA suppressed HCV infection as rapidly as the fastest-acting DAAs. CsA and inhibitors of NS5A and NS3/4A, but not of NS5B, suppressed the production and release of infectious HCV particles. Intriguingly, while CsA rapidly suppressed infectious extracellular virus levels, it had no significant effect on the intracellular infectious virus, suggesting that, unlike the DAAs tested here, it may block a post-assembly step in the viral replication cycle. Hence, our findings shed light on the biological processes involved in HCV replication and the role of CypA.

    Citation

    Dandan Liu, Tanya P Ndongwe, Juan Ji, Andrew D Huber, Eleftherios Michailidis, Charles M Rice, Robert Ralston, Philip R Tedbury, Stefan G Sarafianos. Mechanisms of Action of the Host-Targeting Agent Cyclosporin A and Direct-Acting Antiviral Agents against Hepatitis C Virus. Viruses. 2023 Apr 17;15(4)

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 37112961

    View Full Text